- Follow Us
CDI Labs Services for
HuProt tests and validates that the antibody recognizes its intended target with high specificity.
REQUEST INFOMonoclonal antibody specificity validation is a crucial step in antibody development. Specificity testing validates that the antibody recognizes its intended target with high specificity while exhibiting minimal cross-reactivity with unrelated proteins or molecules.
In the featured publication, HuProt™ microarray was used as the primary validation tool to identify mAbs with high specificity for their cognate targets. A total of 122,662 antibodies were tested using 2 x 7 array format mini-chips, and subsequently 5,882 antibodies were tested on HuProt. The entire pipeline identified 1,406 highly validated immunoprecipitation- and/or immunoblotting-grade mouse monoclonal antibodies against 737 human transcription factors.
Abstract
A key component of efforts to address the reproducibility crisis in biomedical research is the development of rigorously validated and renewable protein-affinity reagents. As part of the US National Institutes of Health (NIH) Protein Capture Reagents Program (PCRP), we have generated a collection of 1,406 highly validated immunoprecipitation- and/or immunoblotting-grade mouse monoclonal antibodies (mAbs) to 737 human transcription factors, using an integrated production and validation pipeline. We used HuProt human protein microarrays as a primary validation tool to identify mAbs with high specificity for their cognate targets.
VIEW PAPER